Q2 2021 Results - Reimagining Medicine

Participants Company overview Pharmaceuticals Oncology Financial performance CRM IHD Neuroscience Oncology Ophthalmology Financial review Conclusion Appendix Innovation: Pipeline overview Respiratory References Innovation: Clinical trials Sandoz Biopharmaceuticals Global Health Abbreviations Clinical Trials Update Includes selected ongoing or recently concluded global trials of Novartis development programs/products which are in confirmatory development or marketed (typically Phase 2b or later). For further information on all Novartis clinical trials, please visit: www.novartisclinicaltrials.com 56 Investor Relations | Q2 2021 Results NOVARTIS | Reimagining Medicine

View entire presentation